Cargando…
Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implications
Treatment guidelines for the COVID-19 treatment are still evolving, moreover, the changing variants of the virus with varying virulence, pose challenges for the healthcare professionals (HCP) not only in managing the primary infection but also a myriad of physical and neuropsychiatric complications....
Autores principales: | Kumar, Akash, Chattopadhyay, Ankita, Gupta, Snehil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986230/ https://www.ncbi.nlm.nih.gov/pubmed/35461033 http://dx.doi.org/10.1016/j.ajp.2022.103101 |
Ejemplares similares
-
Neuropsychiatric manifestations of SARS-CoV-2 infection
por: Nogueira, V., et al.
Publicado: (2021) -
NeuroCOVID: critical review of neuropsychiatric manifestations of SARS-CoV-2 infection
por: Oliveira, Renato, et al.
Publicado: (2020) -
Neuropsychiatric Manifestations of Thyroid Diseases
por: Lekurwale, Vedant, et al.
Publicado: (2023) -
Neuropsychiatric manifestations of methyl iodide toxicity
por: Sidana, Ajeet, et al.
Publicado: (2020) -
Neuropsychiatric manifestations in CADASIL
por: Chabriat, Hugues, et al.
Publicado: (2007)